Metabolic Associated Fatty Liver Disease Is Associated With an Increased Risk of Severe COVID-19: A Systematic Review With Meta-Analysis

MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease

(2020) Mohammed Eslam et al.   GASTROENTEROLOGY

Coronavirus Disease 2019 (COVID-19): A Perspective from China

(2020) Zi Yue Zu et al.   RADIOLOGY

Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission

(2020) Jennifer Lighter et al.   CLINICAL INFECTIOUS DISEASES

Chronic liver disease is not associated with severity or mortality in Coronavirus disease 2019 (COVID-19)

(2020) Giuseppe Lippi et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores

(2020) Giovanni Targher et al.   GUT

Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line

(2020) Arturo Ciccullo et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Metabolic associated fatty liver disease increases COVID‐19 disease severity in non‐diabetic patients

(2020) Feng Gao et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis

(2020) Yu-Jie Zhou et al.   JOURNAL OF HEPATOLOGY

Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study

(2020) Dong Ji et al.   JOURNAL OF HEPATOLOGY

Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020

(2020) Shikha Garg et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19

(2020) G. Targher et al.   DIABETES & METABOLISM

COVID‐19 and nonalcoholic fatty liver disease: two intersecting pandemics

(2020) Piero Portincasa et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis

(2020) Alexander J. Kovalic et al.   Hepatology International

The negative impact of comorbidities on the disease course of COVID-19

(2020) Noémi Zádori et al.   INTENSIVE CARE MEDICINE

Is the increased risk for MAFLD patients to develop severe COVID-19 linked to perturbation of the gut-liver axis?

(2020) Gabriella Assante et al.   JOURNAL OF HEPATOLOGY

Impact of chronic liver disease on outcomes of hospitalized patients with COVID‐19: A multicentre United States experience

(2020) Nikroo Hashemi et al.   LIVER INTERNATIONAL

Metabolic‐associated fatty liver disease is associated with severity of COVID‐19

(2020) Yu‐Jie Zhou et al.   LIVER INTERNATIONAL

Obesity is a risk factor for developing critical condition in COVID‐19 patients: A systematic review and meta‐analysis

(2020) Mária Földi et al.   Obesity Reviews

MAFLD in COVID-19 patients: an insidious enemy

(2020) Paola Dongiovanni et al.   Expert Review of Gastroenterology & Hepatology

COVID-19 in people with diabetes: understanding the reasons for worse outcomes

(2020) Matteo Apicella et al.   Lancet Diabetes & Endocrinology

The COVID-19 Cytokine Storm; What We Know So Far

(2020) Dina Ragab et al.   Frontiers in Immunology

Nonalcoholic fatty liver disease is associated with COVID-19 severity independently of metabolic syndrome

(2020) Mahmud Mahamid et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

A guide to systematic review and meta-analysis of prognostic factor studies

(2019) Richard D Riley et al.   BMJ-British Medical Journal

Assessing Bias in Studies of Prognostic Factors

(2013) Jill A. Hayden et al.   ANNALS OF INTERNAL MEDICINE